10月9日，GSK宣布就其胃灼热药物Zantac致癌问题诉讼案与10家原告公司达成和解，GSK需要为大约80000起诉讼支付22亿美元，为每位索赔人支付大约27500美元，避免其在美国面临的93%州诉讼案。

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

葛兰素史克(GSK.US)跌1.35%，报39.69美元。消息面上，葛兰素史克周三宣布，同意支付高达22亿美元，以解决美国州法院提起的大多数诉讼，这些诉讼指控一种已停产的胃灼热药物Zantac会导致癌症。该公司与10家原告律师事务所达成的协议解决了约 ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...

The Cboe Options Exchange (CBOE) saw more than 1.6 million call contracts and 792,227 put contracts exchanged on Thursday.

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know ...

Zantac was pulled from shelves in 2019 amid panic that a key ingredient - ranitidine - could cause cancer, plunging GSK and ...

（图：法新社）（伦敦11日讯）英国制药巨头葛兰素史克（GSK）宣布，已与10家原告公司达成协议，将支付22亿美元（约94亿令吉）和解，结束美国约8万起“善胃得（Zantac）”诉讼案。另外，该公司也将支付7000万美元，解决另起类似诉讼。这项产品曾在 ...

GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion: London, UK Friday, October 11, 2024, 14:00 Hrs [IST] GSK plc announced that it has reac ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...